Reaction Biology Corporation

Based in Malvern, PA and Freiburg Germany, Reaction Biology Corporation with its wholly owned subsidiary ProQinase is a premier provider of drug screening and profiling services. With more than 650 kinase and 400 epigenetic targets, RBC’s activity assay coverage of the kinome and epigenome are the largest and broadest in the industry. Using its proprietary HotSpotSM technology and other innovations, RBC has provided its services and proteins to over 1,500 customers worldwide, including large pharmaceutical, biotech, government, and academic labs.